カテゴリー： 世界, 医療/バイオ, LP Information

世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年

【英語タイトル】Global Oxycodone Hydrochloride Extended-Release Drug Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10351）・商品コード：LP23DC10351
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の塩酸オキシコドン徐放性薬剤市場」は、過去の販売実績から2022年の世界の塩酸オキシコドン徐放性薬剤の総販売量を検討し、2023年から2029年の予測される塩酸オキシコドン徐放性薬剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の塩酸オキシコドン徐放性薬剤の市場規模を掲載し、XXX百万米ドル規模の世界の塩酸オキシコドン徐放性薬剤市場の詳細な分析を提供します。本インサイトレポートは、世界の塩酸オキシコドン徐放性薬剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の塩酸オキシコドン徐放性薬剤市場における各社の独自のポジションをより深く理解するために、塩酸オキシコドン徐放性薬剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の塩酸オキシコドン徐放性薬剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。塩酸オキシコドン徐放性薬剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。塩酸オキシコドン徐放性薬剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。塩酸オキシコドン徐放性薬剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

塩酸オキシコドン徐放性薬剤の世界主要メーカーとしては、PURDUE PHARMA LP、 Teva Pharmaceutical Industries Ltd、 Epic Pharma, LLC、 Mylan、 Amneal Pharmaceuticals, Inc.（Impax）、 Lifeon Pharmaceutical、 Humanwell Healthcare、 Mallinckrodt Pharmaceuticals、 Pfizerなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の塩酸オキシコドン徐放性薬剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では塩酸オキシコドン徐放性薬剤市場をセグメンテーションし、種類別 (徐放性錠剤、徐放性カプセル)、用途別 (病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：徐放性錠剤、徐放性カプセル

・用途別区分：病院、診療所

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の塩酸オキシコドン徐放性薬剤市場の10年間の市場状況・展望は？
・世界および地域別に見た塩酸オキシコドン徐放性薬剤市場成長の要因は何か？
・塩酸オキシコドン徐放性薬剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・塩酸オキシコドン徐放性薬剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：塩酸オキシコドン徐放性薬剤の年間販売量2018-2029、地域別現状・将来分析
・塩酸オキシコドン徐放性薬剤の種類別セグメント：徐放性錠剤、徐放性カプセル
・塩酸オキシコドン徐放性薬剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・塩酸オキシコドン徐放性薬剤の用途別セグメント：病院、診療所
・塩酸オキシコドン徐放性薬剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の塩酸オキシコドン徐放性薬剤市場
・企業別のグローバル塩酸オキシコドン徐放性薬剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の塩酸オキシコドン徐放性薬剤の年間売上：2018-2023年の売上、市場シェア
・企業別の塩酸オキシコドン徐放性薬剤販売価格
・主要企業の塩酸オキシコドン徐放性薬剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

塩酸オキシコドン徐放性薬剤の地域別レビュー
・地域別の塩酸オキシコドン徐放性薬剤市場規模2018-2023：年間販売量、売上
・主要国別の塩酸オキシコドン徐放性薬剤市場規模2018-2023：年間販売量、売上
・南北アメリカの塩酸オキシコドン徐放性薬剤販売の成長
・アジア太平洋の塩酸オキシコドン徐放性薬剤販売の成長
・ヨーロッパの塩酸オキシコドン徐放性薬剤販売の成長
・中東・アフリカの塩酸オキシコドン徐放性薬剤販売の成長

南北アメリカ市場
・南北アメリカの国別の塩酸オキシコドン徐放性薬剤販売量、売上（2018-2023）
・南北アメリカの塩酸オキシコドン徐放性薬剤の種類別販売量
・南北アメリカの塩酸オキシコドン徐放性薬剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の塩酸オキシコドン徐放性薬剤販売量、売上（2018-2023）
・アジア太平洋の塩酸オキシコドン徐放性薬剤の種類別販売量
・アジア太平洋の塩酸オキシコドン徐放性薬剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の塩酸オキシコドン徐放性薬剤販売量、売上（2018-2023）
・ヨーロッパの塩酸オキシコドン徐放性薬剤の種類別販売量
・ヨーロッパの塩酸オキシコドン徐放性薬剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の塩酸オキシコドン徐放性薬剤販売量、売上（2018-2023）
・中東・アフリカの塩酸オキシコドン徐放性薬剤の種類別販売量
・中東・アフリカの塩酸オキシコドン徐放性薬剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・塩酸オキシコドン徐放性薬剤の製造コスト構造分析
・塩酸オキシコドン徐放性薬剤の製造プロセス分析
・塩酸オキシコドン徐放性薬剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・塩酸オキシコドン徐放性薬剤の主要なグローバル販売業者
・塩酸オキシコドン徐放性薬剤の主要なグローバル顧客

地域別の塩酸オキシコドン徐放性薬剤市場予測レビュー
・地域別の塩酸オキシコドン徐放性薬剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・塩酸オキシコドン徐放性薬剤の種類別市場規模予測
・塩酸オキシコドン徐放性薬剤の用途別市場規模予測

主要企業分析
PURDUE PHARMA LP、 Teva Pharmaceutical Industries Ltd、 Epic Pharma, LLC、 Mylan、 Amneal Pharmaceuticals, Inc.（Impax）、 Lifeon Pharmaceutical、 Humanwell Healthcare、 Mallinckrodt Pharmaceuticals、 Pfizer
・企業情報
・塩酸オキシコドン徐放性薬剤製品
・塩酸オキシコドン徐放性薬剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Oxycodone Hydrochloride Extended-Release Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oxycodone Hydrochloride Extended-Release Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oxycodone Hydrochloride Extended-Release Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oxycodone Hydrochloride Extended-Release Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oxycodone Hydrochloride Extended-Release Drug players cover PURDUE PHARMA LP, Teva Pharmaceutical Industries Ltd, Epic Pharma, LLC, Mylan, Amneal Pharmaceuticals, Inc.（Impax）, Lifeon Pharmaceutical, Humanwell Healthcare, Mallinckrodt Pharmaceuticals and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Oxycodone Hydrochloride Extended-Release Drug Industry Forecast” looks at past sales and reviews total world Oxycodone Hydrochloride Extended-Release Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Oxycodone Hydrochloride Extended-Release Drug sales for 2023 through 2029. With Oxycodone Hydrochloride Extended-Release Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oxycodone Hydrochloride Extended-Release Drug industry.
This Insight Report provides a comprehensive analysis of the global Oxycodone Hydrochloride Extended-Release Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oxycodone Hydrochloride Extended-Release Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oxycodone Hydrochloride Extended-Release Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oxycodone Hydrochloride Extended-Release Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oxycodone Hydrochloride Extended-Release Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Extended-Release Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Extended-Release Tablets
Extended-Release Capsules
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
PURDUE PHARMA LP
Teva Pharmaceutical Industries Ltd
Epic Pharma, LLC
Mylan
Amneal Pharmaceuticals, Inc.（Impax）
Lifeon Pharmaceutical
Humanwell Healthcare
Mallinckrodt Pharmaceuticals
Pfizer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oxycodone Hydrochloride Extended-Release Drug market?
What factors are driving Oxycodone Hydrochloride Extended-Release Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oxycodone Hydrochloride Extended-Release Drug market opportunities vary by end market size?
How does Oxycodone Hydrochloride Extended-Release Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Oxycodone Hydrochloride Extended-Release Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Oxycodone Hydrochloride Extended-Release Drug by Country/Region, 2018, 2022 & 2029
2.2 Oxycodone Hydrochloride Extended-Release Drug Segment by Type
2.2.1 Extended-Release Tablets
2.2.2 Extended-Release Capsules
2.3 Oxycodone Hydrochloride Extended-Release Drug Sales by Type
2.3.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Type (2018-2023)
2.4 Oxycodone Hydrochloride Extended-Release Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Oxycodone Hydrochloride Extended-Release Drug Sales by Application
2.5.1 Global Oxycodone Hydrochloride Extended-Release Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Application (2018-2023)
3 Global Oxycodone Hydrochloride Extended-Release Drug by Company
3.1 Global Oxycodone Hydrochloride Extended-Release Drug Breakdown Data by Company
3.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales by Company (2018-2023)
3.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Company (2018-2023)
3.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Company (2018-2023)
3.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Company (2018-2023)
3.3 Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Company
3.4 Key Manufacturers Oxycodone Hydrochloride Extended-Release Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxycodone Hydrochloride Extended-Release Drug Product Location Distribution
3.4.2 Players Oxycodone Hydrochloride Extended-Release Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oxycodone Hydrochloride Extended-Release Drug by Geographic Region
4.1 World Historic Oxycodone Hydrochloride Extended-Release Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Oxycodone Hydrochloride Extended-Release Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Oxycodone Hydrochloride Extended-Release Drug Sales Growth
4.4 APAC Oxycodone Hydrochloride Extended-Release Drug Sales Growth
4.5 Europe Oxycodone Hydrochloride Extended-Release Drug Sales Growth
4.6 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Growth
5 Americas
5.1 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Country
5.1.1 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2018-2023)
5.1.2 Americas Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2018-2023)
5.2 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Type
5.3 Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Region
6.1.1 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2018-2023)
6.1.2 APAC Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2018-2023)
6.2 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Type
6.3 APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oxycodone Hydrochloride Extended-Release Drug by Country
7.1.1 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2018-2023)
7.1.2 Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2018-2023)
7.2 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Type
7.3 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug by Country
8.1.1 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Type
8.3 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oxycodone Hydrochloride Extended-Release Drug
10.3 Manufacturing Process Analysis of Oxycodone Hydrochloride Extended-Release Drug
10.4 Industry Chain Structure of Oxycodone Hydrochloride Extended-Release Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oxycodone Hydrochloride Extended-Release Drug Distributors
11.3 Oxycodone Hydrochloride Extended-Release Drug Customer
12 World Forecast Review for Oxycodone Hydrochloride Extended-Release Drug by Geographic Region
12.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Size Forecast by Region
12.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Forecast by Region (2024-2029)
12.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oxycodone Hydrochloride Extended-Release Drug Forecast by Type
12.7 Global Oxycodone Hydrochloride Extended-Release Drug Forecast by Application
13 Key Players Analysis
13.1 PURDUE PHARMA LP
13.1.1 PURDUE PHARMA LP Company Information
13.1.2 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.1.3 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 PURDUE PHARMA LP Main Business Overview
13.1.5 PURDUE PHARMA LP Latest Developments
13.2 Teva Pharmaceutical Industries Ltd
13.2.1 Teva Pharmaceutical Industries Ltd Company Information
13.2.2 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.3 Epic Pharma, LLC
13.3.1 Epic Pharma, LLC Company Information
13.3.2 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.3.3 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Epic Pharma, LLC Main Business Overview
13.3.5 Epic Pharma, LLC Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.4.3 Mylan Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Amneal Pharmaceuticals, Inc.（Impax）
13.5.1 Amneal Pharmaceuticals, Inc.（Impax） Company Information
13.5.2 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.5.3 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Amneal Pharmaceuticals, Inc.（Impax） Main Business Overview
13.5.5 Amneal Pharmaceuticals, Inc.（Impax） Latest Developments
13.6 Lifeon Pharmaceutical
13.6.1 Lifeon Pharmaceutical Company Information
13.6.2 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.6.3 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lifeon Pharmaceutical Main Business Overview
13.6.5 Lifeon Pharmaceutical Latest Developments
13.7 Humanwell Healthcare
13.7.1 Humanwell Healthcare Company Information
13.7.2 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.7.3 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Humanwell Healthcare Main Business Overview
13.7.5 Humanwell Healthcare Latest Developments
13.8 Mallinckrodt Pharmaceuticals
13.8.1 Mallinckrodt Pharmaceuticals Company Information
13.8.2 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.8.3 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.8.5 Mallinckrodt Pharmaceuticals Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
13.9.3 Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Oxycodone Hydrochloride Extended-Release Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Oxycodone Hydrochloride Extended-Release Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Extended-Release Tablets
Table 4. Major Players of Extended-Release Capsules
Table 5. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2018-2023)
Table 7. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2018-2023)
Table 12. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Application (2018-2023)
Table 13. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Company (2018-2023)
Table 17. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Oxycodone Hydrochloride Extended-Release Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Oxycodone Hydrochloride Extended-Release Drug Producing Area Distribution and Sales Area
Table 21. Players Oxycodone Hydrochloride Extended-Release Drug Products Offered
Table 22. Oxycodone Hydrochloride Extended-Release Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Oxycodone Hydrochloride Extended-Release Drug
Table 58. Key Market Challenges & Risks of Oxycodone Hydrochloride Extended-Release Drug
Table 59. Key Industry Trends of Oxycodone Hydrochloride Extended-Release Drug
Table 60. Oxycodone Hydrochloride Extended-Release Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Oxycodone Hydrochloride Extended-Release Drug Distributors List
Table 63. Oxycodone Hydrochloride Extended-Release Drug Customer List
Table 64. Global Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Oxycodone Hydrochloride Extended-Release Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. PURDUE PHARMA LP Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 80. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. PURDUE PHARMA LP Main Business
Table 82. PURDUE PHARMA LP Latest Developments
Table 83. Teva Pharmaceutical Industries Ltd Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 85. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Teva Pharmaceutical Industries Ltd Main Business
Table 87. Teva Pharmaceutical Industries Ltd Latest Developments
Table 88. Epic Pharma, LLC Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 90. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Epic Pharma, LLC Main Business
Table 92. Epic Pharma, LLC Latest Developments
Table 93. Mylan Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 95. Mylan Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Amneal Pharmaceuticals, Inc.（Impax） Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 100. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Amneal Pharmaceuticals, Inc.（Impax） Main Business
Table 102. Amneal Pharmaceuticals, Inc.（Impax） Latest Developments
Table 103. Lifeon Pharmaceutical Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 105. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Lifeon Pharmaceutical Main Business
Table 107. Lifeon Pharmaceutical Latest Developments
Table 108. Humanwell Healthcare Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 110. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Humanwell Healthcare Main Business
Table 112. Humanwell Healthcare Latest Developments
Table 113. Mallinckrodt Pharmaceuticals Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 115. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Mallinckrodt Pharmaceuticals Main Business
Table 117. Mallinckrodt Pharmaceuticals Latest Developments
Table 118. Pfizer Basic Information, Oxycodone Hydrochloride Extended-Release Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Oxycodone Hydrochloride Extended-Release Drug Product Portfolios and Specifications
Table 120. Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Oxycodone Hydrochloride Extended-Release Drug
Figure 2. Oxycodone Hydrochloride Extended-Release Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxycodone Hydrochloride Extended-Release Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Extended-Release Tablets
Figure 10. Product Picture of Extended-Release Capsules
Figure 11. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type in 2022
Figure 12. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2018-2023)
Figure 13. Oxycodone Hydrochloride Extended-Release Drug Consumed in Hospital
Figure 14. Global Oxycodone Hydrochloride Extended-Release Drug Market: Hospital (2018-2023) & (K Units)
Figure 15. Oxycodone Hydrochloride Extended-Release Drug Consumed in Clinic
Figure 16. Global Oxycodone Hydrochloride Extended-Release Drug Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2022)
Figure 18. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application in 2022
Figure 19. Oxycodone Hydrochloride Extended-Release Drug Sales Market by Company in 2022 (K Units)
Figure 20. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Company in 2022
Figure 21. Oxycodone Hydrochloride Extended-Release Drug Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Company in 2022
Figure 23. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Oxycodone Hydrochloride Extended-Release Drug Sales 2018-2023 (K Units)
Figure 26. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue 2018-2023 ($ Millions)
Figure 27. APAC Oxycodone Hydrochloride Extended-Release Drug Sales 2018-2023 (K Units)
Figure 28. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue 2018-2023 ($ Millions)
Figure 29. Europe Oxycodone Hydrochloride Extended-Release Drug Sales 2018-2023 (K Units)
Figure 30. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue 2018-2023 ($ Millions)
Figure 33. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country in 2022
Figure 34. Americas Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country in 2022
Figure 35. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2018-2023)
Figure 36. Americas Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2018-2023)
Figure 37. United States Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region in 2022
Figure 42. APAC Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Regions in 2022
Figure 43. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2018-2023)
Figure 44. APAC Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2018-2023)
Figure 45. China Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country in 2022
Figure 53. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country in 2022
Figure 54. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2018-2023)
Figure 55. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2018-2023)
Figure 56. Germany Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2018-2023)
Figure 65. Egypt Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Oxycodone Hydrochloride Extended-Release Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Oxycodone Hydrochloride Extended-Release Drug in 2022
Figure 71. Manufacturing Process Analysis of Oxycodone Hydrochloride Extended-Release Drug
Figure 72. Industry Chain Structure of Oxycodone Hydrochloride Extended-Release Drug
Figure 73. Channels of Distribution
Figure 74. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Forecast by Region (2024-2029)
Figure 75. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年] (コード：LP23DC10351)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の塩酸オキシコドン徐放性錠剤市場予測 2023年-2029年
  • 世界のタムスロシン塩酸塩徐放性カプセル市場予測 2023年-2029年
  • 世界のパリペリドン徐放性錠剤市場予測 2023年-2029年
  • 世界のメトプロロールコハク酸塩徐放錠市場予測 2023年-2029年
  • 世界のネビボロール塩酸塩API市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆